Rationale Patients with fibrotic interstitial lung disease (ILD) frequently develop resting or
exertional hypoxaemia. There is heterogeneity in clinical practice and a paucity of evidence …

In patients with fibrotic interstitial lung disease (ILD), hypoxaemia on exertion is frequent,
and contributes to exercise intolerance, exertional dyspnoea and reduced quality of life [1 …

Long-term oxygen therapy (LTOT) is universally accepted as standard care for patients with
severe resting hypoxaemia, irrespective of underlying diagnosis, with the aim being to …

Rationale: Hypoxemia in fibrotic interstitial lung disease (ILD) indicates disease progression
and is of prognostic significance. The onset of hypoxemia signifies disease progression and …

While high-level evidence is lacking, numerous retrospective studies have depicted the
value of supplemental oxygen in idiopathic pulmonary fibrosis (IPF) and other interstitial …

Interstitial lung disease (ILD) comprises a large and heterogeneous group of disorders that
often lead to progressive fibrosis and premature death. Oxygen supplementation is typically …

Patients with interstitial lung diseases (ILD) often have hypoxemia at rest and/or with
exertion, for which supplemental oxygen is commonly prescribed. The number of patients …

Background: Oxygen therapy is prescribed to treat hypoxaemia in people with interstitial
lung disease (ILD); however, uptake and adherence remain an ongoing challenge. This …

Background Despite a lack of evidence, ambulatory oxygen therapy is frequently prescribed
for patients with interstitial lung disease (ILD) and exertional desaturation. Patients often …

Background and objective Despite its clinical and prognostic significance, few studies have
evaluated the severity of exertional oxygen desaturation in fibrotic interstitial lung disease …